Artemisia annua

Characterization and comparison of transgenic Artemisia annua GYR and wild-type NON-GYR plants in an environmental release trial

H. Liu, Wu, G. G., Wang, J. B., Wu, X., Bai, L., Jiang, W., Lv, B. B., Pan, A. H., Jia, J. W., Li, P., Zhao, K., Jiang, L. X., Tang, X. M., Liu, H., Wu, G. G., Wang, J. B., Wu, X., Bai, L., Jiang, W., Lv, B. B., Pan, A. H., Jia, J. W., Li, P., Zhao, K., Jiang, L. X., and Tang, X. M., Characterization and comparison of transgenic Artemisia annua GYR and wild-type NON-GYR plants in an environmental release trial, vol. 15, p. -, 2016.

The anti-malarial drug, artemisinin, is quite expensive as a result of its slow content in Artemisia annua. Recent investigations have suggested that genetic engineering of A. annua is a promising approach to improve the yield of artemisinin. In this study, the transgenic A. annua strain GYR, which has high artemisinin content, was evaluated in an environmental release trial.

Cloning and characterization of DELLA genes in Artemisia annua

Q. Shen, Cui, J., Fu, X. Q., Yan, T. X., and Tang, K. X., Cloning and characterization of DELLA genes in Artemisia annua, vol. 14, pp. 10037-10049, 2015.

Gibberellins (GA) are some of the most important phytohormones involved in plant development. DELLA proteins are negative regulators of GA signaling in many plants. In this study, the full-length cDNA sequences of three DELLA genes were cloned from Artemisia annua. Phylogenetic analysis revealed that AaDELLA1 and AaDELLA2 were located in the same cluster, but AaDELLA3 was not. Subcellular localization analysis suggested that AaDELLAs can be targeted to the nucleus and/or cytoplasm.

Subscribe to Artemisia annua